Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review

Since the discovery of chlorpromazine (CPZ) in 1952, first-generation antipsychotics (FGAs) have revolutionized psychiatric care in terms of facilitating discharge from hospital and enabling large numbers of patients with severe mental illness (SMI) to be treated in the community. Second-generation...

Descripción completa

Detalles Bibliográficos
Autores principales: Solmi, Marco, Murru, Andrea, Pacchiarotti, Isabella, Undurraga, Juan, Veronese, Nicola, Fornaro, Michele, Stubbs, Brendon, Monaco, Francesco, Vieta, Eduard, Seeman, Mary V, Correll, Christoph U, Carvalho, André F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499790/
https://www.ncbi.nlm.nih.gov/pubmed/28721057
http://dx.doi.org/10.2147/TCRM.S117321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499790/
https://www.ncbi.nlm.nih.gov/pubmed/28721057
http://dx.doi.org/10.2147/TCRM.S117321

Ejemplares similares